To systematically review randomised control trials that have evaluated the efficacy and safety of sarpogrelate hydrochloride versus placebo or other medications for peripheral arterial disease.
We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.